SE8403042L - HYPOLIPIDEMIC COMPOSITION - Google Patents

HYPOLIPIDEMIC COMPOSITION

Info

Publication number
SE8403042L
SE8403042L SE8403042A SE8403042A SE8403042L SE 8403042 L SE8403042 L SE 8403042L SE 8403042 A SE8403042 A SE 8403042A SE 8403042 A SE8403042 A SE 8403042A SE 8403042 L SE8403042 L SE 8403042L
Authority
SE
Sweden
Prior art keywords
hypolipidemic composition
hypolipidemic
composition
benzothiazepin
diltiazem
Prior art date
Application number
SE8403042A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE465352B (en
SE8403042D0 (en
Inventor
K Takashima
S Nitta
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SE8403042D0 publication Critical patent/SE8403042D0/en
Publication of SE8403042L publication Critical patent/SE8403042L/en
Publication of SE465352B publication Critical patent/SE465352B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Hypolipidemic composition comprising as an active ingredient d -3-acetoxy-cis-2,3-dihydro-5-[2- (dimethylamino)-ethyl]-2-(p-methoxyphenyl)-1,5-benzothiazepin -4(5H)-one diltiazem) or a pharmaceutically acceptable acid addition salt thereof.
SE8403042A 1983-06-10 1984-06-06 USE OF DILTIAZEM FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF HYPERLIPIDEMIA SE465352B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (en) 1983-06-10 1983-06-10 Cholesterol-lowering agent

Publications (3)

Publication Number Publication Date
SE8403042D0 SE8403042D0 (en) 1984-06-06
SE8403042L true SE8403042L (en) 1984-12-11
SE465352B SE465352B (en) 1991-09-02

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403042A SE465352B (en) 1983-06-10 1984-06-06 USE OF DILTIAZEM FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OF HYPERLIPIDEMIA

Country Status (12)

Country Link
JP (1) JPS59231018A (en)
BE (1) BE899867A (en)
CH (1) CH661867A5 (en)
DE (1) DE3419425A1 (en)
DK (1) DK164021C (en)
FR (1) FR2547730B1 (en)
GB (1) GB2141027B (en)
HK (1) HK45489A (en)
IT (1) IT1196710B (en)
NL (1) NL8401793A (en)
SE (1) SE465352B (en)
SG (1) SG21089G (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (en) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd Preventive and treating agent for arteriosclerosis
AT389446B (en) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Use of an 8-chlorobenzothiazepine for the production of a medicament
DE3737741A1 (en) * 1987-11-06 1989-05-18 Goedecke Ag ORAL MEDICAL FORM FOR THE ONLY DAILY TREATMENT OF HYPERTENSION WITH DILTIAZEMHYDROCHLORIDE
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (en) * 1982-05-28 1983-12-03 Japan Found Cancer Enhancing agent for effect of antitumor agent
JPS5970611A (en) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd Drug composition

Also Published As

Publication number Publication date
DK284084D0 (en) 1984-06-08
BE899867A (en) 1984-10-01
NL8401793A (en) 1985-01-02
GB8414498D0 (en) 1984-07-11
DE3419425A1 (en) 1984-12-13
FR2547730A1 (en) 1984-12-28
DK284084A (en) 1984-12-11
FR2547730B1 (en) 1987-11-13
SE465352B (en) 1991-09-02
IT8467596A1 (en) 1985-12-08
JPS59231018A (en) 1984-12-25
GB2141027B (en) 1986-10-22
JPS6317810B2 (en) 1988-04-15
DE3419425C2 (en) 1989-06-08
DK164021C (en) 1992-09-28
CH661867A5 (en) 1987-08-31
SG21089G (en) 1990-01-26
IT1196710B (en) 1988-11-25
HK45489A (en) 1989-06-16
DK164021B (en) 1992-05-04
SE8403042D0 (en) 1984-06-06
IT8467596A0 (en) 1984-06-08
GB2141027A (en) 1984-12-12

Similar Documents

Publication Publication Date Title
HRP20000494B1 (en) Pharmaceutically active morpholinol
NO992498D0 (en) Guanidinyl heterocycle compounds useful as <alfa> -2 adrenoceptor agonists
SE8403042D0 (en) HYPOLIPIDEMIC COMPOSITION
DE3874900D1 (en) ACTIVE SUBSTANCE WITH THE DIALETIC EFFECT AND IMPROVING THE KIDNEY FUNCTION AND USE OF A BENZOTHIAZEPINE DERIVATIVE CONTAINING IT.
ES541089A0 (en) PROCEDURE FOR PREPARING A NEW ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF BENZOTIAZEPINE.
FR2673037B1 (en) RESERVE CATHODE FOR EMISSION OF ELETRONS.
EP0420264A3 (en) Transdermal delivery of (+)(2s,3s)-3-acetoxy-8-chloro-5-(2-dimethyl-aminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5h)-one
AU3491889A (en) 2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid, 8'-phenylmenthyl ester, especially for diltiazem
GB2190290B (en) Use of benzothiazepine derivatives in pharmaceutical compositions for improving constitution of lipids in blood.
IT8323108A0 (en) PROCEDURE FOR THE RECOVERY OF CIS(+)-3-ACETYLOXY-5-OPEN SQUARE BRACKET 2-(DIMETHYLAMINO)ETHYL CLOSE SQUARE BRACKET-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTIAZEPIN-4- (5H)-ONE HYDROCHLORIDE.
IT8422701A0 (en) PROCEDURE FOR THE RECOVERY OF CIS(+)-3-ACETYLOXY-5-[2-(DIMETHYLAMINO)ETHYL]-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTIAZEPIN-4-(5H)- ONE HYDROCHLORIDE
IT8420148A0 (en) PROCEDURE FOR THE PREPARATION OF (+)-CIS-5-[2-(DIMETHYLAMINO)ETHYL]-2,3-DIHYDRO-3-HYDROXY-2-(P-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H) -ONE ACETATE HYDROCHLORIDE
IT8521855A0 (en) PROCEDURE FOR THE RECOVERY OF CIS(+)-3-ACETYLOXY-5-[2-(DIMETHYLAMINO)ETHYL]-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-1,5-BENZOTIAZEPIN-4-(5H)- ONE HYDROCHLORIDE
ZA893677B (en) 2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio)propionic acid,8'-phenylmenthyl ester,especially for diltiazem
IT1237204B (en) PROCEDURE FOR THE PREPARATION OF 2-ARIL-3-HYDROXY-CIS-2,3-DIHYDRO- 1,5-BENZOTHIAZEPIN-4 (5H) -ONES AND DERIVATIVES
DK0980383T3 (en) Pharmaceutically acceptable salts of 3-hydroxy-oestr-5 (10) -en-17-one-3-sulfate active as estrogens
ES511830A0 (en) PROCEDURE FOR OBTAINING N-2- (5- (DIMETILANMINO) METHYL-2-FURANIL) METHYL) THIO) ETHYL) -N'-METHYL-2-NITRO-1,1-ETHENO-DIAMINE.
ES279140Y (en) FIXED DENTAL IMPLANT, PERFECTED
ES526086A0 (en) PROCEDURE FOR PREPARING AN AROMATIC OR HETERO-CYCLIC OXAZEPINE OR THIAZEPINE.
IT8620243A0 (en) PROCEDURE FOR THE PREPARATION OF N-[2-[[[5-(DIMETHYLAMINO)METHYL]-2FURANIL] METHYL]THIO] ETHYL]-2-NITRO1,1-ETHENEDIAMINE N'-SUBSTITUTED QUADRA-2-NITRO-1,1 -N'-SUBSTITUTED ETHENDIAMINES.
ES1006702Y (en) MACHINE FOR THE PREPARATION OF FISH.
IT8719138A0 (en) PROCEDURE FOR THE APPLICATION OF A DENTAL PROSTHESIS, WITH AN ENTIRELY SUBMERGED SCREW.
ES1011564Y (en) PERFECTED PORTICO LOADER FOR MACHINE-TOOLS.
ES556216A0 (en) PROCEDURE FOR OBTAINING A BIOLOGICALLY ACTIVE OCTOBLOCK COPOLYMER COMPOSITION.
ES556609A0 (en) A PROCEDURE FOR THE PREPARATION OF A 2- (7-INDENYLOXYMETHYL) MORPHOLINE ACID ADDITION SALT.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8403042-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8403042-8

Format of ref document f/p: F